<!-- logos --><!-- img alt="LaRoche Posay" src="-/media/D3684486FE96443DBD7CEA8FA36D7012.ashx?la=en" _languageinserted="true" /--><!-- img alt="Cerave" src="-/media/CF3A9820FD954271A9BE9661F0487DEB.ashx?la=en" _languageinserted="true" /--><!-- img alt="Vichy" _languageinserted="true" src="-/media/4A811371DE0D44568E2AD44EB27BDFDB.ashx" /--><!-- img alt="SkinCeuticals" _languageinserted="true" src="-/media/F9D36CB888FA4DE3BA9692A72E0DF206.ashx" /--><!-- img alt="SkinBetter" src="-/media/CA8B21B684A44E53AFEE421E32B64004.ashx?la=en" _languageinserted="true" /-->Welcome | 9:00  M. Cohen-Welgryn, B. Chuberre, MDKEYNOTE LECTURE & PANEL DISCUSSION 9:14 - 9:34 | KEYNOTE LECTUREThe Evolution and Many Meaningsof Human Skin ColorN. Jablonski (USA), PhD 9:34 - 10:11 | PANEL DISCUSSION Universal color of dermatology - Research and educational gaps A.Alexis, MD, MPH (USA)  N. Jablonski (USA), PhD D. Ncoza, MD (South Africa)  J.Wangari, PhD (USA)10:13 - 11:13 |Understandingand managingHyperpigmentationChair: A. Alexis MD,MPH (USA)10:13 - 10:28 |Epidemiological study ofpigmentation disorders and impacton QOLand stigmatisation10:28 - 10:48 |New insights in the physiopathologyof hyperpigmentation and clinicalimpactT.Passeron, MD (FR), F. Bernerd, PhD(FR)  10:48 - 11:08 | New topical agent forhyperpigmentation management(melasyl)  P. Sextius, PhD (FR), D. Kerob, MD (FR)11:45 - 12:45 |Supporting Skin Healthaccess worldwideChair: E. Freeman, MD, PhD (USA)11:45 - 12:05 |Overview on inequality of SkinHealth Access worldwideD. Ncoza, MD (South Africa) & E. Freeman, MD, PhD 12:05 - 12:20Teledermatology to supportundeserved population healthaccessT. Maurer, MD (USA)12:20 - 12:35 |WHO Initiatives to support SkinHealth AccessJ. A. Ruis Postigo, MD (CH)  12:35 - 12:50 | L’Oreal Initiatives to support SkinHealth Access    E. Freeman, MD,PhD, M. Cohen-Welgryn14:25 | Improving worldwidePhotoprotectionChair: B.Dreno, MD (FR)14:25 - 14:40 | Worldwide photoprotection habitsresults of an epidemiological study J. Krutmann, MD (DE)14:40 - 14:55 | Innovation in photoprotectionintegrating long UVA,visible lightsand skin colors diversity F. Bernerd, PhD15:00 - 16:06 | Unraveling the Complexitiesof Dry Skin and MatureXerosisChair : E. Berardesca, MD (IT)15:01 - 15:16 | Overview Skin barrier structurefunctionE. Berardesca, MD (IT)15:16 - 15:31 | Racial/Ethnic variations in skinbarrier structure, function, andcomposition in dry, atopic skinA. Alexis, MD, MPH (USA)15:31 - 15:46 | Advanced Methods for EvaluatingEmollients: The BRaCE studyS. Danby, PhD (UK)15:46 - 16:01 | Mature Xerosis: alterations in barrierstructure, function & compositionwith age J. Fluhr, MD (GER)16:36 - 17:11 | Exploring the ExposomeChair : E. Berardesca, MD (IT)16:36 - 16:51 | New insights in the external andinternal factors impacting skinhealth using cohort studyL.Aguilar, PhD (FR)16:51 - 17:06 | Skin conditions variation relatedto women hormonal change - anepidemiological study accross 20countries in women aged 18-55 yearsC. Zouboulis, MD, PhD (GER)17:11 - 18:02 | Pioneering Advances inMicrobiome DermatologicalResearchChair: B.Dreno, MD (FR)17:12 - 17:27 | Skin Microbiome What's new?B.Dreno, MD (FR)17:27 - 17:42 | Microbiome as a new target foraging ?M. Moreau, PhD (FR) 17:42 - 17:57 | Microbiome transplantation in SkinCancer  C. Alves-Costa-Silva, MD PhD (FR) ⬅ Back